Comparing Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) and Monogram Orthopaedics (NASDAQ:MGRM)

Monogram Orthopaedics (NASDAQ:MGRMGet Free Report) and Inspira Technologies Oxy B.H.N. (NASDAQ:IINNGet Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, earnings and dividends.

Institutional and Insider Ownership

0.5% of Monogram Orthopaedics shares are held by institutional investors. Comparatively, 12.7% of Inspira Technologies Oxy B.H.N. shares are held by institutional investors. 28.1% of Monogram Orthopaedics shares are held by company insiders. Comparatively, 29.4% of Inspira Technologies Oxy B.H.N. shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Monogram Orthopaedics and Inspira Technologies Oxy B.H.N.’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Monogram Orthopaedics N/A -130.90% -106.38%
Inspira Technologies Oxy B.H.N. N/A N/A N/A

Earnings and Valuation

This table compares Monogram Orthopaedics and Inspira Technologies Oxy B.H.N.”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Monogram Orthopaedics $370,000.00 265.21 -$13.74 million ($0.47) -6.09
Inspira Technologies Oxy B.H.N. N/A N/A -$11.29 million N/A N/A

Inspira Technologies Oxy B.H.N. has lower revenue, but higher earnings than Monogram Orthopaedics.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Monogram Orthopaedics and Inspira Technologies Oxy B.H.N., as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Monogram Orthopaedics 0 0 1 1 3.50
Inspira Technologies Oxy B.H.N. 0 0 0 0 0.00

Monogram Orthopaedics currently has a consensus price target of $4.00, indicating a potential upside of 39.86%. Given Monogram Orthopaedics’ stronger consensus rating and higher probable upside, research analysts clearly believe Monogram Orthopaedics is more favorable than Inspira Technologies Oxy B.H.N..

Risk & Volatility

Monogram Orthopaedics has a beta of 1.51, suggesting that its stock price is 51% more volatile than the S&P 500. Comparatively, Inspira Technologies Oxy B.H.N. has a beta of 2.13, suggesting that its stock price is 113% more volatile than the S&P 500.

Summary

Inspira Technologies Oxy B.H.N. beats Monogram Orthopaedics on 6 of the 11 factors compared between the two stocks.

About Monogram Orthopaedics

(Get Free Report)

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas.

About Inspira Technologies Oxy B.H.N.

(Get Free Report)

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.

Receive News & Ratings for Monogram Orthopaedics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monogram Orthopaedics and related companies with MarketBeat.com's FREE daily email newsletter.